XML 57 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Mar. 31, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Financial Statement Amounts of the Consolidated VIEs

The following financial statement amounts of the consolidated VIEs were included in net income (loss) from discontinued operation in the accompanying consolidated statements of operations and comprehensive (loss) income.

 

    For the years ended March 31,  
    2026     2025     2024  
    USD     USD     USD  
Net revenues                 694  
Net loss                 (12,479 )

 

    For the years ended March 31,  
    2026     2025     2024  
    USD     USD     USD  
Net cash provided by operating activities                 12,497  
Net cash (used in) investing activities                  
Net cash provided by financing activities                 213,879  
Schedule of Revenue

For the years ended March 31, 2026, 2025 and 2024, the revenue of the Company illustrated as below:

 

    For the years ended March 31,  
    2026     2025     2024  
Revenues                  
Revenue from sale of medical devices   $     $ 415,020     $ 2,416,797  
Revenue from marketing promotion service     13,835,063       14,366,602        
Total revenues   $ 13,835,063     $ 14,781,622     $ 2,416,797  
Business and sales related taxes     (3,159 )     (3,824 )     (2,459 )
Net revenues   $ 13,831,904     $ 14,777,798     $ 2,414,338  
Schedule of Estimated Useful Lives of Property and Equipment

Property and equipment are stated at cost. Depreciation and amortization are calculated using the straight—line method over the following estimated useful lives:

 

    Useful
life
 
Office equipment   1—3 years  
Schedule of Intangible Assets Estimated Useful Lives Separately identifiable intangible assets that have determinable lives continue to be amortized over their estimated useful lives using the straight—line method as follows:
Category   Estimated
useful
lives
 
Software   3-4 years  
Patent   10 years  
License   4.4 years  
Schedule of Noncontrolling Interest

Noncontrolling interest consist of the following:

 

    March 31,
2026
    March 31,
2025
 
    USD     USD  
We Healthy     (12,233 )     31,991  
Schedule of Spot Exchange Rates and Average Exchange Rates

Spot exchange rates and average exchange rates were used in the translation of the consolidated financial statements.

 

    For the years ended March 31,  
    2026     2025     2024  
US Exchange Rate                  
Year—end RMB     6.8980       7.2567       7.2203  
Year average RMB     7.1019       7.2163       7.1671